Abstract: An electronic assembly includes a circuit board assembly and a liquid cold plate. The circuit board assembly includes a board, a first heat-generating component, and a second heat-generating component, where the first heat-generating component and the second heat-generating component are disposed on the board. The liquid cold plate includes a liquid inlet and a liquid outlet. The liquid cold plate includes a first cooling region and a second cooling region, where the second cooling region is closer to the liquid outlet than the first cooling region. A heat dissipation capability of the first cooling region is stronger than that of the second cooling region. A heat-generating density of the first heat-generating component is greater than that of the second heat-generating component, the first heat-generating component is thermally connected to the first cooling region, and the second heat-generating component is thermally connected to the second cooling region.

Abstract: Systems and methods of rendering effects are described herein. A computing device can receive a user selection of an effect to be applied during gameplay of a computer game. The computing device can initiate a framework with which to apply the effect during the gameplay. The computing device can determine scenes during the gameplay to apply the effect through the framework. The computing device can determine graphical elements in the scenes that correspond to non-user interface elements through the framework. The computing system can apply the effect to the graphical elements through the framework.

Abstract: Personal care topical compositions at skin-tolerant pH with cystine which is solubilized or has small crystal size below 20 microns. A process of making the composition is also described.

Abstract: Disclosed is a multi-phase personal care composition comprising an aqueous phase, and an oil phase comprising volatile silicone, fatty acid amide and retinoid, wherein the aqueous phase is visually distinct from and in physical contact with the oil phase.

Abstract: Personal care topical compositions at skin-tolerant pH with cystine which is solubilized or has small crystal size below 20 microns. A process of making the composition is also described.

Abstract: Disclosed is a method for obtaining multileaflet Medicago sativa materials by means of MsPALM1 artificial site-directed mutants. The method comprises: selecting a target site from an exon region of a compound leaf developmental regulatory gene MsPALM1 of Medicago sativa and constructing a plant CRISPR/Cas9 editing recombinant vector MsCRISPR/Cas9::PALM1 and introducing the vector into Medicago sativa cells and regenerating into plants, cutting and repairing to cause a loss-of-function mutation in the MsPALM1 gene of Medicago sativa cells, and then screening the mutant plants by restriction endonuclease digestion and/or targeted deep sequencing of the target sites of the regenerated plants to obtain lines carrying four MsPALM1 allelic genes with simultaneous loss of function mutation. After phenotypic identification, it was confirmed that the compound leaves of the regenerated plants changed from three leaflets to five leaflets.

Abstract: Personal care topical compositions at skin-tolerant pH with cystine which is solubilized or has small crystal size below 20 microns. A process of making the composition is also described.

Abstract: Colorant Compositions free of cochineal red are described. The colorant compositions mimic the color of cochineal red and they are stable in the pressure of active materials typically found in cosmetic compositions.

Abstract: Big data health service method and system based on remote fundus screening are provided. The method includes steps of: acquiring information to be analyzed sent by remote terminal agency; pre-interpreting information to be analyzed, and judging whether information to be analyzed is qualified; extracting characteristic data from information to be analyzed if it is qualified, and forming structured quantitative index; sorting and analyzing characteristic data and quantitative index according to knowledge calculation model to obtain analysis conclusion; and storing information to be analyzed, characteristic data, quantitative index, and analysis conclusion into pre-designed database.

Abstract: A quality control method for remote fundus screening includes acquiring a fundus image of an examinee through a fundus camera by terminal application institution and transmitting the fundus image as well as personal information and inquiry data which are carried by the examinee to a remote interpretation and consultation center. The remote interpretation consultation center determines whether the fundus image, personal information, and consultation data are qualified; if the fundus image, personal information, and consultation data are unqualified, the remote interpretation consultation center terminates the interpretation.

Abstract: The present invention relates to fundus image processing field, especially a preprocessing method for quantitative analysis of fundus image, and storage device. A preprocessing method for quantitative analysis of fundus image, wherein the step includes, acquiring a to-be-processed fundus image; performing optic disk positioning on the to-be-processed fundus image; performing macular fovea positioning on the to-be-processed image; and calculating a quantization parameter of a distance between a center of the macular fovea and a bitamporal edge of the optic disk. Through this method, the data obtained is converted from absolute representation to relative representation, and through normalization, a meaningful and comparable quantification is formed between people, between different people, and even between inspection results of different instruments. analyze data. It ensures that fundus images from different sources can form meaningful and comparable quantitative indicators.

Abstract: The subject matter described herein includes methods, systems, and computer readable media for automated behavioral assessment. According to one aspect, a method for automated behavioral assessment is provided. The method occurs at a computing platform including a processor and memory. The method includes providing at least one stimulus for eliciting a response from a user. The method also includes obtaining, using a camera or sensor communicatively coupled to the computing platform, the at least one response. The method also includes determining, using the at least one response, a behavioral assessment associated with the user.

Abstract: A method for site-specific mutagenesis of Medicago sativa genes by using a CRISPR/Cas9 system. The method comprises: first constructing a binary expression vector MsCRISPR/Cas9 that can be used for transforming Medicago sativa by Agrobacterium tumefaciens; then designing a target site for a target gene, and ligating the DNA fragment containing the guide sequence of the target site into MsCRISPR/Cas9 to construct a vector MsCRISPR/Cas9::target; and then transforming the Medicago sativa by Agrobacterium tumefaciens, and generating, by screening, a mutant transformed plant with the target gene mutated. According to the method, an MtU6 promoter is used for driving sgRNA transcription in the Medicago sativa.

Abstract: Disclosed is a method for obtaining multileaflet Medicago sativa materials by means of MsPALM1 artificial site-directed mutants. The method comprises: selecting a target site from an exon region of a compound leaf developmental regulatory gene MsPALM1 of Medicago sativa and constructing a plant CRISPR/Cas9 editing recombinant vector MsCRISPR/Cas9::PALM1 and introducing the vector into Medicago sativa cells and regenerating into plants, cutting and repairing to cause a loss-of-function mutation in the MsPALM1 gene of Medicago sativa cells, and then screening the mutant plants by restriction endonuclease digestion and/or targeted deep sequencing of the target sites of the regenerated plants to obtain lines carrying four MsPALM1 allelic genes with simultaneous loss of function mutation. After phenotypic identification, it was confirmed that the compound leaves of the regenerated plants changed from three leaflets to five leaflets.

Abstract: Disclosed is a method for obtaining multileaflet Medicago sativa materials by means of MsPALM1 artificial site-directed mutants. The method comprises: selecting a target site from an exon region of a compound leaf developmental regulatory gene MsPALM1 of Medicago sativa and constructing a plant CRISPR/Cas9 editing recombinant vector MsCRISPR/Cas9::PALM1 and introducing the vector into Medicago sativa cells and regenerating into plants, cutting and repairing to cause a loss-of-function mutation in the MsPALM1 gene of Medicago sativa cells, and then screening the mutant plants by restriction endonuclease digestion and/or targeted deep sequencing of the target sites of the regenerated plants to obtain lines carrying four MsPALM1 allelic genes with simultaneous loss of function mutation. After phenotypic identification, it was confirmed that the compound leaves of the regenerated plants changed from three leaflets to five leaflets.

Abstract: A method for site-specific mutagenesis of Medicago sativa genes by using a CRISPR/Cas9 system. The method comprises: first constructing a binary expression vector MsCRISPR/Cas9 that can be used for transforming Medicago sativa by Agrobacterium tumefaciens; then designing a target site for a target gene, and ligating the DNA fragment containing the guide sequence of the target site into MsCRISPR/Cas9 to construct a vector MsCRISPR/Cas9::target; and then transforming the Medicago sativa by Agrobacterium tumefaciens, and generating, by screening, a mutant transformed plant with the target gene mutated. According to the method, an MtU6 promoter is used for driving sgRNA transcription in the Medicago sativa.

Abstract: Personal care topical compositions at skin-tolerant pH with cystine which is solubilized or has small crystal size below 20 microns. A process of making the composition is also described.

Abstract: The present invention relates to an antimicrobial composition and more particularly an antimicrobial composition for leave-on applications. The present invention discloses an antimicrobial composition comprising; a) 0.01 to 2% by weight of thymol; b) 0.01 to 2% by weight of terpineol; and c) 0.1 to 2% by weight of a cationic phospholipid complex.

Abstract: Compositions for coloring skin are described. The compositions comprise beads that comprise petrolatum and optionally a colorant and the beads have a diameter from about 90 to about 625 microns. When applied topically, the compositions unexpectedly yield long lasting color.